Glioblastoma (combination with active agents / newly diagnosed or recurrent) | XPORT-GBM-029

Indication: GBM
Title: SEAL: A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Drug: selinexor

Please visit clinicaltrials.gov for more information about this study.